|
Volumn 30, Issue 5, 1998, Pages 1652-1653
|
Generic substitution for cyclosporine: What should we be looking for in new formulations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
GENERIC DRUG;
BIOEQUIVALENCE;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG FORMULATION;
DRUG QUALITY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
ORAL DRUG ADMINISTRATION;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK FACTOR;
CYCLOSPORINE;
DOSAGE FORMS;
DRUGS, GENERIC;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
RISK FACTORS;
|
EID: 0031683119
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00377-7 Document Type: Conference Paper |
Times cited : (15)
|
References (28)
|